The present study has combined RNF43 expression and CD163+ TAM accumulation into a prognostic model with TNM stage, which shows robust accuracy in forecasting the postoperative outcome of ccRCC patients than that achieved with only single indicators. The gene discussed is CD163; the disease is nonpapillary renal cell carcinoma.